Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding

Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding

The targets for licensed drugs used for the treatment of human immunodeficiency virus type 1 (HIV-1) are confined to the viral reverse transcriptase (RT), protease (PR), and the gp41 transmembrane protein (TM). While currently approved drugs are effective in controlling HIV-1 infections, new drug ta...

Full description

Bibliographic Details
Main Authors: Johanna Wapling, Seema Srivastava, Miranda Shehu-Xhilaga, Gilda Tachedjian Ph.D.
Format: Article
Language:English
Published: AboutScience Srl 2007-01-01
Series:Drug Target Insights
Online Access:https://doi.org/10.1177/117739280700200020

Similar Items

Similar Items